The rapid growth of radiopharmaceuticals is creating pressure on the manufacturing and supply infrastructure needed to support new diagnostic and cancer treatments. The global radiopharmaceutical market is estimated to be worth approximately $11 billion in 2026 and is projected to exceed $20 billion by 2030, says GlobalData, a leading intelligence and productivity platform. GlobalData’s monthly […]